4-fluoropiperidine orexin receptor antagonists
US9550786B2 · kind B2 · utility
17Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2014 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | Jan 13, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to 4-fluoropiperidine compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.